[1]郭琪,姚昶,郭宇飞,等.龟鹿三黄汤联合钙剂对乳腺癌内分泌治疗患者骨代谢异常的影响[J].中国中医药信息杂志,2020,27(9):41-45.[doi:10.3969/j.issn.1005-5304.202001230]
 GUO Qi,YAO Chang,GUO Yufei,et al.Effects of Guilu Sanhuang Decoction Combined with Calcium on Bone Metabolism in Patients with Breast Cancer Treated by Endocrine Therapy[J].zhongguo zhongyiyao xinxi zazhi,2020,27(9):41-45.[doi:10.3969/j.issn.1005-5304.202001230]
点击复制

龟鹿三黄汤联合钙剂对乳腺癌内分泌治疗患者骨代谢异常的影响

参考文献/References:

[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality woridwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,60(10):1-31.

[2] SEIFFERT K, SCHMALFELDT B, MÜLLER V. Current status of targeted treatment in breast cancer[J]. Dtsch Med Wochens-chr,2017, 142(22):1669-1675.

[3] LIU Z, ZHANG Y, FRANZIN L, et al. Trends and variations in breast and colorectal cancer incidence from 1995 to 2011:a comparative study between texas cancer registry and national cancer institute’s surveillance, epidemiology and end results data[J]. Int J Oncol,2015,46(4):1819-1826.

[4] TAKAGI K, MIKI Y, ISHIDA T, et al. The interplay of endocrine therapy, steroid pathways and therapeutic resistance:Importance of androgen in breast carcinoma[J]. Mol Cell Endocrinol,2018,466:31-37.

[5] 张孟哲,杜如辛,徐鑫,等.蒋士卿辨治乳腺癌内分泌药物治疗后不良反应经验[J].中医学报,2018,33(1):15-17.

[6] 王江涛,陈绪,姚昶,等.慢性氧化应激激活GSK3β/β-catenin信号通路增强乳腺癌细胞MCF-7活性的机制研究[J].南京中医药大学学报, 2019,35(6):691-698.

[7] NCCN?. NCCN clinincal practice guidelines in oncology (NCCN Gidelines?) breast cancer (2017.V3) [EB/OL]. (2017-11-15)[2018-01-01]. https://www.nccn.org/.

[8] 张俐.中医骨病学[M].北京:人民卫生出版社,2012:119-130.

[9] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:245-246.

[10] 秦叔逵,马军,游伟程,等.中国临床肿瘤学进展2010[M].北京:人民卫生出版社,2010:11-59.

[11] 中国康复医学会.常用康复治疗技术操作规范[M].北京:人民卫生出版社,2012:36-37.

[12] 中国乳腺癌内分泌治疗专家共识专家组.中国乳腺癌内分泌治疗专家共识(2015年版)[J].中国癌症杂志,2015,25(9):755-760.

[13] 任留梅,卫红艳,翟琼莉.骨质疏松与乳腺癌骨转移[J].中华乳腺病杂志(电子版),2011,5(4):486-492.

[14] 许秋琳,陈舲,金会,等.乳腺癌骨转移患者中医证候分布及组合规律研究[J].中国中医药信息杂志,2019,26(11):22-26.

[15] 姜菊玲,马文心,卢雯平.三阴乳腺癌中医辨治思路探讨[J].中国中医药信息杂志,2018,25(7):95-98.

[16] 李熙灿,谢学明,黄春花,等.龟板醇提物对大鼠骨髓间充质干细胞氧化损伤的修复及其抗脂质过氧化作用[J].中草药,2007,38(7):1043- 1046.

[17] 陈佳静,姚昶.三黄煎剂干预绝经后激素受体阳性乳腺癌患者慢性应激状态临床研究[J].辽宁中医药大学学报,2018,20(4):147-150.

[18] 许岩磊,叶小舟,唐甜,等.三黄煎剂改善乳腺癌患者围手术期炎症反应的研究[J].中国临床研究,2017,30(2):259-262.

[19] ANGIN E, ERDEN Z, CAN F. The effects of clinical pilates exercises on bone mineral density, physical performance and quality of life of women with postmenopausal osteoporosis[J]. J Back Musculoskelet Rehabil,2015,28(4):849-858.

[20] NAEEM S T, HUSSAIN R, RAHEEM A, et al. Bone turnover markers for osteoporosis status assessment at baseline in postmenopausal pakistani females[J]. J Coll Physicians Surg Pak,2016,26(5):408-412.

[21] 钱海燕,陈慧敏,杜明亮,等.成骨细胞特异性识别多肽对人成骨细胞增殖和矿化影响的实验研究[J].安徽医科大学学报,2016,51(3):337- 340.

[22] OGATA M, IDE R, TAKIZAWA M, et al. Association between basal metabolic function and bone metabolism in postmenopausal women with type 2 diabetes[J]. Nutrition,2015,31(11/12):1394-1401.

[23] 迟海燕,周玉萍,王永笛.2型糖尿病肾病不同分期血清N端骨钙素、Ⅰ型胶原氨基端延长肽、β-胶原降解产物的变化[J].中国骨质疏松杂志, 2015,21(7):855-857,865.

相似文献/References:

[1]廖明娟,蒉 纲,王永灵,等.灌注冲洗和垫棉压迫法治疗乳腺癌术后皮下空腔63例[J].中国中医药信息杂志,2010,17(11):78.
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(9):78.
[2]程旭锋,刘胜.乳腺癌的病机转化及其从肝论治[J].中国中医药信息杂志,2010,17(4):91.
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(9):91.
[3]赵婧.谈温阳法治疗乳腺疾病[J].中国中医药信息杂志,2010,17(9):88.[doi:10.3969/j.issn.1005-5304.2010.09.049]
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(9):88.[doi:10.3969/j.issn.1005-5304.2010.09.049]
[4]赵婧,指导:魏品康.魏品康从痰论治乳腺癌三步法[J].中国中医药信息杂志,2010,17(10):87.[doi:10.3969/j.issn.1005-5304.2010.10.047]
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(9):87.[doi:10.3969/j.issn.1005-5304.2010.10.047]
[5]陈良良,许红霞.中药外敷内服治疗乳腺癌术后上肢水肿体会[J].中国中医药信息杂志,2008,15(9):60.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(9):60.
[6]高甦,王笑民,杨国旺,等.疏肝通络中药配合理疗治疗乳腺癌术后上肢淋巴水肿疗效观察[J].中国中医药信息杂志,2011,18(8):63.[doi:10.3969/j.issn.1005-5304.2011.08.026]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(9):63.[doi:10.3969/j.issn.1005-5304.2011.08.026]
[7]赵婧,刘胜,刘佳.266例乳腺癌术后患者5年生存分析[J].中国中医药信息杂志,2011,18(10):21.[doi:10.3969/j.issn.1005-5304.2011.10.008]
 ZHAO Jing,LIU Sheng,LIU Jia.The 5-year Survival Analysis of 266 Postoperative Breast Cancer Patients[J].zhongguo zhongyiyao xinxi zazhi,2011,18(9):21.[doi:10.3969/j.issn.1005-5304.2011.10.008]
[8]李仕金.乳腺癌系统治疗与生存关系的探讨[J].中国中医药信息杂志,2006,13(5):79.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(9):79.
[9]徐巍,卢雯萍.从中医体质学说研究乳腺癌癌前病变[J].中国中医药信息杂志,2006,13(10):90.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(9):90.
[10]高雅静,卢雯平,邱瑞瑾.疏肝益肾方加减治疗乳腺癌化疗脑142例[J].中国中医药信息杂志,2013,20(9):70.[doi:10.3969/j.issn.1005-5304.2013.09.025]
 [J].zhongguo zhongyiyao xinxi zazhi,2013,20(9):70.[doi:10.3969/j.issn.1005-5304.2013.09.025]

备注/Memo

基金项目:江苏省中医院高峰学术人才培养(k2018yrc11)

更新日期/Last Update:

2020-08-20